Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease.
R Asaad BakshAndré StrydomBen CarterIsabelle CarriereKaren RitchiePublished in: Alzheimer's & dementia (Amsterdam, Netherlands) (2024)
Emax modeling could be used to design more efficient trials which has implications for randomized control trials targeting the earlier stages of AD.